Exploratory biomarkers in MONARCH 1, a phase II study of abemaciclib monotherapy in hormone-receptor positive (HR) HER2-metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Tolaney, S. M.; Cortes, J.; Dickler, M. N.; Zamora, E.; Caldwell, C. W.; Nguyen, T. S.; Nanda, S.; Koustenis, A.; Rugo, H. S. |
| Abstract Title: | Exploratory biomarkers in MONARCH 1, a phase II study of abemaciclib monotherapy in hormone-receptor positive (HR) HER2-metastatic breast cancer (MBC) |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi552 |
| Language: | English |
| ACCESSION: | WOS:000393913000690 |
| DOI: | 10.1093/annonc/mdw435.01 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA12 -- Source: Wos |
